Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Immunogen, Inc. (IMGN) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Immunogen, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 855654.
Total stock buying since 2014: $447,991.
Total stock sales since 2014: $93,904,656.
Total stock option exercises since 2014: $28,454,796.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 0 | $0 | 227,015 | $6,714,941 | 291,326 | $990,318 |
| 2023 | 0 | $0 | 4,558,070 | $79,965,597 | 4,704,335 | $25,040,375 |
| 2021 | 0 | $0 | 0 | $0 | 83,000 | $272,655 |
| 2020 | 0 | $0 | 146,954 | $740,160 | 45,400 | $0 |
| 2019 | 0 | $0 | 3,038 | $16,013 | 0 | $0 |
| 2018 | 30,000 | $172,800 | 461,099 | $4,271,633 | 141,667 | $536,751 |
| 2017 | 0 | $0 | 41,454 | $282,242 | 50,000 | $225,000 |
| 2016 | 84,375 | $150,082 | 15,563 | $180,964 | 51,168 | $177,270 |
| 2015 | 10,000 | $125,109 | 145,740 | $1,678,610 | 213,131 | $1,112,431 |
| 2014 | 0 | $0 | 5,240 | $54,496 | 17,421 | $99,996 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-02 | 0 | $0 | 39,348 | $1,152,492 | 103,659 | $0 |
| 2024-01 | 0 | $0 | 187,667 | $5,562,449 | 187,667 | $990,318 |
| 2023-12 | 0 | $0 | 123,993 | $3,647,620 | 162,445 | $739,191 |
| 2023-11 | 0 | $0 | 709,438 | $13,629,492 | 616,595 | $4,714,734 |
| 2023-10 | 0 | $0 | 192,004 | $2,764,857 | 212,004 | $1,171,418 |
| 2023-09 | 0 | $0 | 192,013 | $2,964,680 | 209,815 | $1,442,369 |
| 2023-08 | 0 | $0 | 3,340,622 | $56,958,948 | 3,503,476 | $16,972,663 |
| 2021-09 | 0 | $0 | 0 | $0 | 83,000 | $272,655 |
| 2020-12 | 0 | $0 | 11,052 | $70,511 | 27,240 | $0 |
| 2020-04 | 0 | $0 | 5,448 | $18,686 | 18,160 | $0 |
| 2020-02 | 0 | $0 | 130,454 | $650,963 | 0 | $0 |
| 2019-01 | 0 | $0 | 3,038 | $16,013 | 0 | $0 |
| 2018-11 | 30,000 | $172,800 | 0 | $0 | 0 | $0 |
| 2018-10 | 0 | $0 | 5,851 | $46,808 | 0 | $0 |
| 2018-09 | 0 | $0 | 5,851 | $55,350 | 0 | $0 |
| 2018-06 | 0 | $0 | 10,000 | $110,200 | 10,000 | $30,500 |
| 2018-03 | 0 | $0 | 35,000 | $415,700 | 35,000 | $137,750 |
| 2018-02 | 0 | $0 | 404,397 | $3,643,575 | 96,667 | $368,501 |
| 2017-09 | 0 | $0 | 38,550 | $262,954 | 50,000 | $225,000 |
| 2017-01 | 0 | $0 | 2,904 | $19,288 | 0 | $0 |
| 2016-12 | 20,000 | $36,000 | 0 | $0 | 0 | $0 |
| 2016-11 | 64,375 | $114,082 | 0 | $0 | 0 | $0 |
| 2016-06 | 0 | $0 | 0 | $0 | 27,085 | $86,401 |
| 2016-02 | 0 | $0 | 3,889 | $31,971 | 14,778 | $61,187 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-02-05 | Lentini Renee (VP & PRIN ACCTG OFFICER) | Sale | 2,631 | 29.30 | 77,088 |
| 2024-02-05 | Coen Stacy Ann (SVP & CHIEF BUSINESS OFFICER) | Sale | 4,583 | 29.30 | 134,281 |
| 2024-02-05 | Enyedy Mark J (CHIEF EXECUTIVE OFFICER) | Sale | 20,107 | 29.28 | 588,732 |
| 2024-02-05 | Wingrove Theresa (SVP OF REGULATORY AFFAIRS) | Sale | 12,027 | 29.30 | 352,391 |
| 2024-02-02 | Lentini Renee (VP & PRIN ACCTG OFFICER) | Option Ex | 8,435 | .00 | 0 |
| 2024-02-02 | Coen Stacy Ann (SVP & CHIEF BUSINESS OFFICER) | Option Ex | 14,350 | .00 | 0 |
| 2024-02-02 | Enyedy Mark J (CHIEF EXECUTIVE OFFICER) | Option Ex | 51,234 | .00 | 0 |
| 2024-02-02 | Wingrove Theresa (SVP OF REGULATORY AFFAIRS) | Option Ex | 29,640 | .00 | 0 |
| 2024-01-16 | Wingrove Theresa (SVP OF REGULATORY AFFAIRS) | Sale | 187,667 | 29.64 | 5,562,449 |
| 2024-01-16 | Wingrove Theresa (SVP OF REGULATORY AFFAIRS) | Option Ex | 187,667 | 5.28 | 990,318 |
| 2023-12-29 | Coen Stacy Ann (SVP & CHIEF BUSINESS OFFICER) | Option Ex | 30,000 | 5.32 | 159,600 |
| 2023-12-26 | Lentini Renee (VP & PRIN ACCTG OFFICER) | Sale | 6,548 | 29.74 | 194,737 |
| 2023-12-22 | Lentini Renee (VP & PRIN ACCTG OFFICER) | Option Ex | 15,000 | .00 | 0 |
| 2023-12-15 | Wingrove Theresa (SVP OF REGULATORY AFFAIRS) | Sale | 117,445 | 29.40 | 3,452,883 |
| 2023-12-15 | Wingrove Theresa (SVP OF REGULATORY AFFAIRS) | Option Ex | 117,445 | 4.93 | 579,591 |
| 2023-11-30 | Coen Stacy Ann (SVP & CHIEF BUSINESS OFFICER) | Sale | 3,826 | 29.20 | 111,719 |
| 2023-11-30 | Wingrove Theresa (SVP OF REGULATORY AFFAIRS) | Sale | 164,424 | 28.95 | 4,760,074 |
| 2023-11-30 | Wingrove Theresa (SVP OF REGULATORY AFFAIRS) | Option Ex | 164,424 | 10.72 | 1,762,625 |
| 2023-11-30 | Peterson Kristine | Sale | 20,000 | 28.90 | 578,000 |
| 2023-11-30 | Peterson Kristine | Option Ex | 20,000 | 11.59 | 231,700 |
| 2023-11-29 | Wingrove Theresa (SVP OF REGULATORY AFFAIRS) | Sale | 6,792 | 16.66 | 113,154 |
| 2023-11-29 | Wingrove Theresa (SVP OF REGULATORY AFFAIRS) | Option Ex | 6,792 | 10.65 | 72,334 |
| 2023-11-17 | Coen Stacy Ann (SVP & CHIEF BUSINESS OFFICER) | Sale | 78,223 | 16.05 | 1,255,479 |
| 2023-11-17 | Coen Stacy Ann (SVP & CHIEF BUSINESS OFFICER) | Option Ex | 78,223 | 6.30 | 493,196 |
| 2023-11-16 | Coen Stacy Ann (SVP & CHIEF BUSINESS OFFICER) | Sale | 4,100 | 16.01 | 65,641 |
| 2023-11-16 | Coen Stacy Ann (SVP & CHIEF BUSINESS OFFICER) | Option Ex | 4,100 | 6.30 | 25,850 |
| 2023-11-15 | Coen Stacy Ann (SVP & CHIEF BUSINESS OFFICER) | Sale | 26,286 | 16.01 | 420,838 |
| 2023-11-15 | Coen Stacy Ann (SVP & CHIEF BUSINESS OFFICER) | Option Ex | 26,286 | 6.30 | 165,733 |
| 2023-11-15 | Wingrove Theresa (SVP OF REGULATORY AFFAIRS) | Sale | 166,725 | 15.85 | 2,642,591 |
| 2023-11-15 | Wingrove Theresa (SVP OF REGULATORY AFFAIRS) | Option Ex | 166,725 | 4.55 | 758,598 |
| 2023-11-07 | Wingrove Theresa (SVP OF REGULATORY AFFAIRS) | Sale | 19,517 | 16.66 | 325,153 |
| 2023-11-07 | Wingrove Theresa (SVP OF REGULATORY AFFAIRS) | Option Ex | 19,517 | 10.65 | 207,856 |
| 2023-11-07 | Wallace Richard John | Option Ex | 10,000 | 14.70 | 147,000 |
| 2023-11-06 | Lentini Renee (VP & PRIN ACCTG OFFICER) | Sale | 219,545 | 15.29 | 3,356,843 |
| 2023-11-06 | Lentini Renee (VP & PRIN ACCTG OFFICER) | Option Ex | 120,528 | 7.05 | 849,842 |
| 2023-10-30 | Goldberg Mark Alan | Option Ex | 20,000 | 14.89 | 297,800 |
| 2023-10-16 | Wingrove Theresa (SVP OF REGULATORY AFFAIRS) | Sale | 192,004 | 14.40 | 2,764,857 |
| 2023-10-16 | Wingrove Theresa (SVP OF REGULATORY AFFAIRS) | Option Ex | 192,004 | 4.55 | 873,618 |
| 2023-09-22 | Mitchell Dean J | Option Ex | 10,000 | 14.70 | 147,000 |
| 2023-09-15 | Wingrove Theresa (SVP OF REGULATORY AFFAIRS) | Sale | 192,013 | 15.44 | 2,964,680 |
| 2023-09-15 | Wingrove Theresa (SVP OF REGULATORY AFFAIRS) | Option Ex | 108,668 | 3.43 | 372,405 |
| 2023-09-13 | Peterson Kristine | Option Ex | 20,000 | 15.39 | 307,800 |
| 2023-09-13 | Mccluski Stephen C | Option Ex | 20,000 | 15.38 | 307,500 |
| 2023-09-12 | Lentini Renee (PRIN. FIN & ACCTG. OFF.) | Option Ex | 25,141 | 4.28 | 107,678 |
| 2023-09-08 | Coen Stacy Ann (SVP & CHIEF BUSINESS OFFICER) | Option Ex | 26,006 | 7.69 | 199,986 |
| 2023-08-09 | Coen Stacy Ann (SVP & CHIEF BUSINESS OFFICER) | Sale | 100,210 | 14.20 | 1,422,982 |
| 2023-08-09 | Coen Stacy Ann (SVP & CHIEF BUSINESS OFFICER) | Option Ex | 100,210 | 4.92 | 493,033 |
| 2023-08-04 | Coen Stacy Ann (SVP & CHIEF BUSINESS OFFICER) | Sale | 80,326 | 17.05 | 1,369,558 |
| 2023-08-04 | Coen Stacy Ann (SVP & CHIEF BUSINESS OFFICER) | Option Ex | 80,326 | 4.92 | 395,203 |
| 2023-08-04 | Enyedy Mark J (CHIEF EXECUTIVE OFFICER) | Sale | 992,397 | 16.96 | 16,831,053 |
| 2023-08-04 | Enyedy Mark J (CHIEF EXECUTIVE OFFICER) | Option Ex | 1,104,218 | 5.15 | 5,686,722 |
| 2023-08-03 | Lentini Renee (PRIN. FIN & ACCTG. OFF.) | Option Ex | 51,033 | 2.49 | 126,919 |
| 2023-08-03 | Enyedy Mark J (CHIEF EXECUTIVE OFFICER) | Sale | 1,020,000 | 16.61 | 16,942,200 |
| 2023-08-03 | Enyedy Mark J (CHIEF EXECUTIVE OFFICER) | Option Ex | 1,020,000 | 4.90 | 4,998,000 |
| 2023-08-02 | Lentini Renee (PRIN. FIN & ACCTG. OFF.) | Sale | 148,277 | 17.55 | 2,602,261 |
| 2023-08-02 | Lentini Renee (PRIN. FIN & ACCTG. OFF.) | Option Ex | 148,277 | 4.88 | 723,888 |
| 2023-08-02 | Coen Stacy Ann (SVP & CHIEF BUSINESS OFFICER) | Sale | 4,255 | 18.12 | 77,100 |
| 2023-08-02 | Coen Stacy Ann (SVP & CHIEF BUSINESS OFFICER) | Option Ex | 4,255 | 4.92 | 20,934 |
| 2023-08-02 | Enyedy Mark J (CHIEF EXECUTIVE OFFICER) | Sale | 995,157 | 17.80 | 17,713,794 |
| 2023-08-02 | Enyedy Mark J (CHIEF EXECUTIVE OFFICER) | Option Ex | 995,157 | 4.55 | 4,527,964 |
| 2021-09-03 | Mitchell Dean J | Option Ex | 83,000 | 3.29 | 272,655 |
| 2020-12-31 | Foster David G (V.P.-Fin., Prin. Acctg. Off.) | Sale | 11,052 | 6.38 | 70,511 |
| 2020-12-31 | Foster David G (V.P.-Fin., Prin. Acctg. Off.) | Option Ex | 27,240 | .00 | 0 |
| 2020-04-02 | Foster David G (V.P.-Fin., Prin. Acctg. Off.) | Sale | 5,448 | 3.43 | 18,686 |
| 2020-04-01 | Foster David G (V.P.-Fin., Prin. Acctg. Off.) | Option Ex | 18,160 | .00 | 0 |
| 2020-02-24 | Ryll Thomas (SVP, Technical Operations) | Sale | 16,790 | 4.99 | 83,782 |
| 2020-02-24 | Berkenblit Anna (SVP & Chief Medical Officer) | Sale | 25,803 | 4.99 | 128,756 |
| 2020-02-24 | Enyedy Mark J (Chief Executive Officer) | Sale | 55,222 | 4.99 | 275,557 |
| 2020-02-24 | Wingrove Theresa (SVP of Regulatory Affairs) | Sale | 16,147 | 4.99 | 80,573 |
| 2020-02-24 | Barrows Craig (Executive VP, General Counsel) | Sale | 16,492 | 4.99 | 82,295 |
| 2019-01-07 | Gregory Richard J. (Executive VP & CSO) | Sale | 3,038 | 5.27 | 16,013 |
| 2018-11-06 | Goldberg Mark Alan | Buy | 30,000 | 5.76 | 172,800 |
| 2018-10-16 | Berkenblit Anna (VP & Chief Medical Officer) | Sale | 5,851 | 8.00 | 46,808 |
| 2018-09-10 | Berkenblit Anna (VP & Chief Medical Officer) | Sale | 5,851 | 9.46 | 55,350 |
| 2018-06-06 | Johnston David Brannon (Chief Financial Officer) | Sale | 10,000 | 11.02 | 110,200 |
| 2018-06-06 | Johnston David Brannon (Chief Financial Officer) | Option Ex | 10,000 | 3.05 | 30,500 |
| 2018-03-16 | Junius Daniel M | Sale | 25,000 | 12.02 | 300,400 |
| 2018-03-16 | Junius Daniel M | Option Ex | 25,000 | 4.29 | 107,250 |
| 2018-03-15 | Johnston David Brannon (Chief Financial Officer) | Sale | 10,000 | 11.53 | 115,300 |
| 2018-03-15 | Johnston David Brannon (Chief Financial Officer) | Option Ex | 10,000 | 3.05 | 30,500 |
| 2018-02-22 | Ryll Thomas (VP, Technical Operations) | Sale | 11,495 | 5.60 | 64,371 |
| 2018-02-22 | Berkenblit Anna (VP & Chief Medical Officer) | Sale | 16,562 | 5.60 | 92,747 |
| 2018-02-22 | Gregory Richard J. (Executive VP & CSO) | Sale | 36,643 | 5.60 | 205,200 |
| 2018-02-22 | Enyedy Mark J (Chief Executive Officer) | Sale | 51,070 | 5.60 | 285,992 |
| 2018-02-22 | Wingrove Theresa (VP of Regulatory Affairs) | Sale | 11,032 | 5.60 | 61,779 |
| 2018-02-22 | Barrows Craig (Executive VP, General Counsel) | Sale | 14,870 | 5.60 | 83,272 |
| 2018-02-21 | Ryll Thomas (VP, Technical Operations) | Sale | 11,876 | 10.88 | 129,210 |
| 2018-02-21 | Berkenblit Anna (VP & Chief Medical Officer) | Sale | 17,329 | 10.88 | 188,539 |
| 2018-02-21 | Gregory Richard J. (Executive VP & CSO) | Sale | 34,486 | 10.88 | 375,207 |
| 2018-02-21 | Enyedy Mark J (Chief Executive Officer) | Sale | 67,717 | 10.87 | 736,083 |
| 2018-02-21 | Wingrove Theresa (VP of Regulatory Affairs) | Sale | 11,379 | 10.88 | 123,803 |
| 2018-02-21 | Johnston David Brannon (Chief Financial Officer) | Sale | 21,060 | 10.87 | 228,922 |
| 2018-02-21 | Barrows Craig (Executive VP, General Counsel) | Sale | 15,498 | 10.88 | 168,618 |
| 2018-02-21 | Junius Daniel M | Sale | 11,713 | 12.00 | 140,556 |
| 2018-02-20 | Junius Daniel M | Sale | 25,000 | 11.68 | 292,000 |
| 2018-02-13 | Junius Daniel M | Sale | 46,667 | 10.01 | 467,276 |
| 2018-02-13 | Junius Daniel M | Option Ex | 71,667 | 3.79 | 261,251 |
| 2017-09-15 | Barrows Craig (Executive VP, General Counsel) | Sale | 22,450 | 6.73 | 151,043 |
| 2017-09-15 | Barrows Craig (Executive VP, General Counsel) | Option Ex | 30,000 | 4.50 | 135,000 |
| 2017-09-13 | Berkenblit Anna (VP & Chief Medical Officer) | Sale | 1,500 | 7.00 | 10,500 |
| 2017-09-13 | Barrows Craig (Executive VP, General Counsel) | Sale | 14,600 | 6.95 | 101,411 |
| 2017-09-13 | Barrows Craig (Executive VP, General Counsel) | Option Ex | 20,000 | 4.50 | 90,000 |
| 2017-01-08 | Gregory Richard J. (Executive VP & CSO) | Sale | 2,904 | 6.64 | 19,288 |
| 2016-12-15 | Goldberg Mark Alan | Buy | 20,000 | 1.80 | 36,000 |
| 2016-11-08 | Enyedy Mark J (Chief Executive Officer) | Buy | 25,000 | 1.83 | 45,750 |
| 2016-11-02 | Gregory Richard J. (Executive VP & CSO) | Buy | 16,600 | 1.78 | 29,597 |
| 2016-11-02 | Johnston David Brannon (Chief Financial Officer) | Buy | 10,000 | 1.70 | 16,980 |
| 2016-11-02 | Lambert John (Executive Vice President) | Buy | 2,775 | 1.69 | 4,675 |
| 2016-11-02 | Barrows Craig (Vice-President,General Counsel) | Buy | 10,000 | 1.71 | 17,080 |
| 2016-06-02 | Junius Daniel M | Option Ex | 27,085 | 3.19 | 86,401 |
| 2016-02-26 | Lambert John (Executive Vice President) | Option Ex | 10,889 | 4.48 | 48,782 |
| 2016-02-01 | Lambert John (Executive Vice President) | Sale | 3,889 | 8.22 | 31,971 |
| 2016-02-01 | Lambert John (Executive Vice President) | Option Ex | 3,889 | 3.19 | 12,405 |
| 2016-01-08 | Gregory Richard J. (Executive VP & CSO) | Sale | 2,369 | 11.10 | 26,305 |
| 2016-01-04 | Lambert John (Executive Vice President) | Sale | 3,889 | 13.20 | 51,338 |
| 2016-01-04 | Lambert John (Executive Vice President) | Option Ex | 3,889 | 3.19 | 12,405 |
| 2016-01-04 | Junius Daniel M (Chief Executive Officer) | Sale | 5,416 | 13.17 | 71,350 |
| 2016-01-04 | Junius Daniel M (Chief Executive Officer) | Option Ex | 5,416 | 3.19 | 17,277 |
| 2015-12-01 | Lambert John (Executive Vice President) | Sale | 3,889 | 13.11 | 50,977 |
| 2015-12-01 | Lambert John (Executive Vice President) | Option Ex | 3,889 | 3.19 | 12,405 |
| 2015-12-01 | Junius Daniel M (Chief Executive Officer) | Sale | 5,416 | 13.11 | 71,025 |
| 2015-12-01 | Junius Daniel M (Chief Executive Officer) | Option Ex | 5,416 | 3.19 | 17,277 |
| 2015-11-27 | Morris Charles Q (Executive VP & CDO) | Sale | 5,170 | 14.00 | 72,380 |
| 2015-11-17 | Mitchell Dean J | Buy | 10,000 | 12.51 | 125,109 |
| 2015-11-03 | Junius Daniel M (Chief Executive Officer) | Option Ex | 5,907 | 4.29 | 25,341 |
| 2015-11-02 | Lambert John (Executive Vice President) | Sale | 3,889 | 11.73 | 45,625 |
| 2015-11-02 | Lambert John (Executive Vice President) | Option Ex | 3,889 | 3.19 | 12,405 |
| 2015-11-02 | Junius Daniel M (Chief Executive Officer) | Sale | 5,497 | 12.00 | 65,964 |
| 2015-11-02 | Junius Daniel M (Chief Executive Officer) | Option Ex | 5,497 | 3.19 | 17,535 |
| 2015-10-30 | Junius Daniel M (Chief Executive Officer) | Option Ex | 5,697 | 5.03 | 28,655 |
| 2015-10-29 | Junius Daniel M (Chief Executive Officer) | Sale | 5,335 | 12.01 | 64,073 |
| 2015-10-29 | Junius Daniel M (Chief Executive Officer) | Option Ex | 5,335 | 3.19 | 17,018 |
| 2015-10-01 | Lambert John (Executive Vice President) | Sale | 3,889 | 9.55 | 37,128 |
| 2015-10-01 | Lambert John (Executive Vice President) | Option Ex | 3,889 | 3.19 | 12,405 |
| 2015-09-17 | Johnston David Brannon (Chief Financial Officer) | Sale | 5,000 | 15.00 | 75,000 |
| 2015-09-17 | Johnston David Brannon (Chief Financial Officer) | Option Ex | 5,000 | 10.79 | 53,949 |
| 2015-09-09 | Junius Daniel M (Chief Executive Officer) | Option Ex | 4,899 | 5.77 | 28,267 |
| 2015-09-01 | Lambert John (Executive Vice President) | Sale | 3,889 | 13.16 | 51,187 |
| 2015-09-01 | Lambert John (Executive Vice President) | Option Ex | 3,889 | 3.19 | 12,405 |
| 2015-09-01 | Junius Daniel M (Chief Executive Officer) | Sale | 5,416 | 13.15 | 71,236 |
| 2015-09-01 | Junius Daniel M (Chief Executive Officer) | Option Ex | 5,416 | 3.19 | 17,277 |
| 2015-08-17 | Junius Daniel M (Chief Executive Officer) | Option Ex | 12,310 | 5.77 | 71,028 |
| 2015-08-03 | Johnston David Brannon (Chief Financial Officer) | Sale | 5,000 | 17.04 | 85,180 |
| 2015-08-03 | Johnston David Brannon (Chief Financial Officer) | Option Ex | 5,000 | 10.79 | 53,949 |
| 2015-08-03 | Lambert John (Executive Vice President) | Sale | 3,889 | 17.10 | 66,509 |
| 2015-08-03 | Lambert John (Executive Vice President) | Option Ex | 3,889 | 3.19 | 12,405 |
| 2015-08-03 | Junius Daniel M (Chief Executive Officer) | Sale | 5,416 | 17.03 | 92,245 |
| 2015-08-03 | Junius Daniel M (Chief Executive Officer) | Option Ex | 5,416 | 3.19 | 17,277 |
| 2015-07-01 | Lambert John (Executive Vice President) | Sale | 3,888 | 14.34 | 55,769 |
| 2015-07-01 | Lambert John (Executive Vice President) | Option Ex | 3,888 | 3.19 | 12,402 |
| 2015-07-01 | Junius Daniel M (Chief Executive Officer) | Sale | 5,416 | 14.34 | 77,676 |
| 2015-07-01 | Junius Daniel M (Chief Executive Officer) | Option Ex | 5,416 | 3.19 | 17,277 |
| 2015-06-15 | Onetto Nicole | Sale | 3,211 | 13.86 | 44,494 |
| 2015-06-15 | Onetto Nicole | Option Ex | 3,211 | 7.82 | 25,110 |
| 2015-06-01 | Lambert John (Executive Vice President) | Sale | 15,000 | 11.78 | 176,640 |
| 2015-06-01 | Lambert John (Executive Vice President) | Option Ex | 15,000 | 5.35 | 80,250 |
| 2015-05-07 | Junius Daniel M (Chief Executive Officer) | Sale | 1,215 | 8.02 | 9,744 |
| 2015-05-07 | Junius Daniel M (Chief Executive Officer) | Option Ex | 1,215 | 5.74 | 6,974 |
| 2015-05-04 | Junius Daniel M (Chief Executive Officer) | Option Ex | 10,647 | 5.74 | 61,113 |
| 2015-05-01 | Lambert John (Executive Vice President) | Sale | 10,000 | 8.32 | 83,180 |
| 2015-05-01 | Lambert John (Executive Vice President) | Option Ex | 10,000 | 5.35 | 53,500 |
| 2015-05-01 | Junius Daniel M (Chief Executive Officer) | Sale | 35,315 | 8.36 | 295,198 |
| 2015-05-01 | Junius Daniel M (Chief Executive Officer) | Option Ex | 35,315 | 5.74 | 202,708 |
| 2015-04-21 | Junius Daniel M (Chief Executive Officer) | Option Ex | 6,969 | 5.74 | 40,002 |
| 2015-04-02 | Junius Daniel M (Chief Executive Officer) | Option Ex | 26,132 | 5.74 | 149,997 |
| 2015-04-01 | Lambert John (Executive Vice President) | Sale | 10,000 | 8.74 | 87,380 |
| 2015-04-01 | Lambert John (Executive Vice President) | Option Ex | 10,000 | 5.35 | 53,500 |
| 2014-11-28 | Morris Charles Q (Executive VP & CDO) | Sale | 5,240 | 10.40 | 54,496 |
| 2014-09-19 | Junius Daniel M (Chief Executive Officer) | Option Ex | 17,421 | 5.74 | 99,996 |
Insider trading activities including stock purchases, stock sales, and option exercises of IMGN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Immunogen, Inc. (symbol IMGN, CIK number 855654) see the Securities and Exchange Commission (SEC) website.